Institutional investors purchased a net $3.1 million shares of CCXI during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 62.02% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TFS CAPITAL LLC Bought 24.8 Thousand shares of ChemoCentryx Inc
VANGUARD INVESTMENTS AUSTRALIA L... Sold 1.4 Thousand shares of ChemoCentryx Inc
APERIO GROUP LLC Sold 25.2 Thousand shares of ChemoCentryx Inc